Cargando…
Newborn screening for spinal muscular atrophy in Japan: One year of experience
Spinal muscular atrophy (SMA) is a degenerative neuromuscular disease that causes progressive muscle weakness and atrophy due to loss of the anterior horn cells of the spinal cord. Although effective treatments, such as gene therapy, have emerged in recent years, their therapeutic efficacy depends o...
Autores principales: | Sawada, Takaaki, Kido, Jun, Sugawara, Keishin, Yoshida, Shinichiro, Ozasa, Shiro, Nomura, Keiko, Okada, Kentaro, Fujiyama, Natsumi, Nakamura, Kimitoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356196/ https://www.ncbi.nlm.nih.gov/pubmed/35942129 http://dx.doi.org/10.1016/j.ymgmr.2022.100908 |
Ejemplares similares
-
Newborn screening for Gaucher disease in Japan
por: Sawada, Takaaki, et al.
Publicado: (2022) -
Frequency of iduronate-2-sulfatase gene variants detected in newborn screening for mucopolysaccharidosis type II in Japan
por: Hattori, Yusuke, et al.
Publicado: (2023) -
Newborn screening for Fabry disease in the western region of Japan
por: Sawada, Takaaki, et al.
Publicado: (2020) -
High-Risk Screening for Fabry Disease: A Nationwide Study in Japan and Literature Review
por: Sawada, Takaaki, et al.
Publicado: (2021) -
Current status of newborn screening for Pompe disease in Japan
por: Sawada, Takaaki, et al.
Publicado: (2021)